We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nontoxic QD Nanoparticles Inhibit Cancer Cell Growth

By LabMedica International staff writers
Posted on 29 May 2018
An environmentally friendly method has been developed for the production of quantum dot nanoparticles, which have antimicrobial properties and demonstrate potential for cancer diagnosis and treatment.

Low-dimensional (<10 nanometer) semiconductor quantum dots (QDs) have received great attention for potential use in biomedical applications (diagnosis and therapy) for which larger nanoparticles (>10 nanometers) are not suitable. More...
However, the chemical synthesis of quantum dots is complicated, expensive, and has toxic side effects.

To avoid these toxic effects, investigators at Swansea University (United Kingdom) developed a non-toxic plant-based alternative method of producing quantum dots, using tealeaf extract. Extracts derived from tealeaves (Camellia sinensis) contain a wide variety of compounds, including polyphenols, amino acids, vitamins, and antioxidants. The investigators added tealeaf extract to a mixture of cadmium sulfate (CdSO4) and sodium sulfide (Na2S) and allowed the solution to incubate until quantum dots formed.

The investigators examined the biological activity of these CdS QDs in different applications, namely, (a) antibacterial activity, (b) bioimaging, and (c) apoptosis of lung cancer cells. The antibacterial activity of the CdS QDs was evaluated and showed that CdS QDs effectively inhibited bacterial growth.

The investigators further reported in the March 9, 2018, online edition of the journal Applied Nano Materials that the quantum dots exhibited cytotoxicity toward A549 lung cancer cells when compared to a control (no QD treatment). The cytotoxic effect on A549 cancer cells was comparable to that of a standard drug, cisplatin. Furthermore, these CdS QDs produced high-contrast fluorescence images of A549 cancer cells indicating a strong interaction with the cancer cell.

To further understand the role of CdS QDs in bioimaging and the cytotoxic effect in A549 cells, the investigators performed fluorescence emission and flow cytometry analyses. The flow cytometry analysis confirmed that the CdS QDs were arresting A549 cell growth at the S phase of the cell cycle, inhibiting further growth of these lung cancer cells.

Senior author Dr. Sudhagar Pitchaimuthu, senior research fellow in engineering at Swansea University, said, "Our research confirmed previous evidence that tea leaf extract can be a non-toxic alternative to making quantum dots using chemicals. The real surprise, however, was that the dots actively inhibited the growth of the lung cancer cells. We had not been expecting this. The CdS quantum dots derived from tealeaf extract showed exceptional fluorescence emission in cancer cell bioimaging compared to conventional CdS nanoparticles. Quantum dots are therefore a very promising avenue to explore for developing new cancer treatments. Building on this exciting discovery, the next step is to scale up our operation, hopefully with the help of other collaborators. We want to investigate the role of tealeaf extract in cancer cell imaging, and the interface between quantum dots and the cancer cell. We would like to set up a "quantum dot factory" which will allow us to explore more fully the ways in which they can be used."

Related Links:
Swansea University


Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
New
Platelet Function Analyzer
PL-12
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.